There is a pressing, global need for new therapies for neglected diseases such as Tuberculosis, Leishmaniasis and Chagas. Traditional lead discovery approaches, while effective have not been widely applied to neglected diseases as they are expensive and time consuming. At Institut Pasteur Korea, we have developed a core technology that enables the high content screening of hundreds of thousands of small molecules against the disease of interest. In doing so, we utilize relevant disease models that allow us to interrogate the disease in the context of the cell and the host-pathogen factors required for invasion, replication, persistence and release. The application of this core technology against Tuberculosis, Leishmaniasis and Chagas disease has resulted in the identification of novel, active compounds in less time and at less cost than traditional drug discovery methods. As these active compounds were identified in a cellular context, they can provide a more relevant starting point for new therapies.
. 2011 Jan 10;5(Suppl 1):P38. doi: 10.1186/1753-6561-5-S1-P38
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
Jonathan Cechetto
1,✉, Hee Kyoung Jeon
1, Jiyeon Jang
1, Doyoon Kwon
1, Thierry Christophe
1, Priscille Brodin
2, Gyongseon Yang
3, Jair Neto
3, Lucio Freitas Junior
3
Jonathan Cechetto
1Screening Technology Platforms, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Jonathan Cechetto
Hee Kyoung Jeon
1Screening Technology Platforms, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Hee Kyoung Jeon
Jiyeon Jang
1Screening Technology Platforms, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Jiyeon Jang
Doyoon Kwon
1Screening Technology Platforms, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Doyoon Kwon
Thierry Christophe
1Screening Technology Platforms, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Thierry Christophe
Priscille Brodin
2Biology of Intracellular Pathogens, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Priscille Brodin
Gyongseon Yang
3Center for Neglected Diseases, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Gyongseon Yang
Jair Neto
3Center for Neglected Diseases, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Jair Neto
Lucio Freitas Junior
3Center for Neglected Diseases, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
Find articles by Lucio Freitas Junior
1Screening Technology Platforms, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
2Biology of Intracellular Pathogens, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
3Center for Neglected Diseases, Institut Pasteur Korea, Seongnam-si, 463-400, Korea
✉
Corresponding author.
Supplement
Institut Pasteur International Network Annual Scientific Meeting
Roberto Bruzzone
Conference
22–23 November 2010
Institut Pasteur International Network Annual Scientific Meeting
Hong Kong
Collection date 2011.
Copyright ©2011 Cechetto et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC3019463
